Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial
PaperCitations, authors & open-access status
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 164 citations, 2022 year and hybrid oa status.
164
Citations
2022
Year
hybrid
OA Status